Variable | Estimate | Std. error | Statistic | p-value |
---|---|---|---|---|
(Intercept) | 63.286 | 5.816 | 10.882 | 0.000 |
Age (years) Age 50–60 | − 5.180 | 4.903 | − 1.057 | 0.291 |
Age 60–70 | − 4.998 | 4.813 | − 1.039 | 0.299 |
Age 70–80 | − 8.099 | 4.870 | − 1.663 | 0.097 |
Age > 80 | − 14.204 | 5.153 | − 2.756 | 0.006 |
Male | 3.975 | 1.228 | 3.236 | 0.001 |
Highest education level Secondary school | − 2.180 | 2.041 | − 1.068 | 0.286 |
Academic high school | 0.551 | 4.332 | 0.127 | 0.899 |
University | − 2.660 | 4.434 | − 0.600 | 0.549 |
Other education levels | − 6.579 | 2.477 | − 2.656 | 0.008 |
GOLD stage (5 years before) GOLD stage 2 | 0.391 | 1.790 | 0.218 | 0.827 |
GOLD stage 3 | − 3.943 | 2.230 | − 1.768 | 0.077 |
GOLD stage 4 | − 4.226 | 3.619 | − 1.168 | 0.243 |
BMI group Class II obesity | − 0.986 | 1.367 | − 0.721 | 0.471 |
Class III obesity | − 4.888 | 2.016 | − 2.425 | 0.015 |
Smoking status (5 years before) Active during DMP | − 3.375 | 1.390 | − 2.427 | 0.015 |
Total no. of exacerbations (5 years before) Severe exacerbations | − 2.847 | 2.404 | − 1.184 | 0.237 |
Medium exacerbations | 0.036 | 0.376 | 0.097 | 0.923 |
Sleep apnea | − 4.344 | 1.786 | − 2.432 | 0.015 |
Charlson Index (5 years before) Myocardial infarction | − 2.907 | 2.920 | − 0.996 | 0.320 |
Congestive heart failure | − 0.774 | 1.394 | − 0.556 | 0.579 |
Peripheral vascular disease | 0.402 | 1.591 | 0.253 | 0.800 |
Cerebrovascular accident | − 3.280 | 1.677 | − 1.956 | 0.051 |
Rheumatic disease (%) | − 1.716 | 2.504 | − 0.685 | 0.493 |
Peptic ulcer disease | − 1.336 | 4.111 | − 0.325 | 0.745 |
Mild liver disease | − 0.567 | 1.329 | − 0.427 | 0.670 |
Diabetes mellitus (uncomplicated) | 0.660 | 1.398 | 0.472 | 0.637 |
Diabetes mellitus (complicated) | − 0.500 | 1.756 | − 0.285 | 0.776 |
Renal disease | − 2.778 | 1.784 | − 1.557 | 0.120 |
Cancer | − 1.100 | 2.021 | − 0.544 | 0.586 |
ICD-10 diagnoses (1 year before) | ||||
Chapter I: certain infectious and parasitic diseases | 0.415 | 2.705 | 0.153 | 0.878 |
Chapter III: diseases of the blood (…) | 6.776 | 2.472 | 2.741 | 0.006 |
Chapter V: mental and behavioral disorders | − 2.988 | 1.935 | − 1.544 | 0.123 |
Chapter VI: diseases of the nervous system | − 0.921 | 1.312 | − 0.702 | 0.483 |
Chapter VII: diseases of the eye and adnexa | − 4.972 | 3.903 | − 1.274 | 0.203 |
Chapter XII: diseases of the skin and subcutaneous tissue | − 3.976 | 2.109 | − 1.885 | 0.060 |
Chapter XIV: diseases of the genitourinary system | 1.757 | 1.076 | 1.633 | 0.103 |
Chapter XVIII: symptoms (…) | − 4.599 | 1.271 | − 3.619 | 0.000 |
Chapter XIX: injury, poisoning (…) | − 1.911 | 1.839 | − 1.039 | 0.299 |
Chapter XXI: factors influencing health status | − 0.158 | 0.992 | − 0.159 | 0.874 |
Severe exacerbations (1 year before) | − 0.266 | 1.447 | − 0.184 | 0.854 |
FEV1% predicted | 0.054 | 0.033 | 1.645 | 0.100 |
BMI increase | − 5.473 | 1.890 | − 2.895 | 0.004 |